2,2'-dipicolylamine has been researched along with Acute Confusional Senile Dementia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, Z; Liu, L; Wang, X; Xu, C; Yang, T; Yin, E; Zhang, C; Zhang, L; Zhu, Z | 1 |
| Benjamin Naman, C; Cui, W; Dong, J; He, S; Huang, X; Jin, H; Lin, D; Liu, F; Liu, H; Liu, Z; Mao, Y; Mou, C; Wang, N; Wang, Z; Wei, J; Xie, Y; Yang, M; Zhang, B; Zhang, P; Zhou, F; Zou, J | 1 |
2 other study(ies) available for 2,2'-dipicolylamine and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Inhibiting Aβ toxicity in Alzheimer's disease by a pyridine amine derivative.
Topics: Alzheimer Disease; Amines; Amyloid beta-Peptides; Animals; Caenorhabditis elegans; Dose-Response Relationship, Drug; Humans; Mice; Mice, Transgenic; Molecular Structure; Neuroprotective Agents; PC12 Cells; Protein Aggregates; Pyridines; Rats; Reactive Oxygen Species; Structure-Activity Relationship | 2019 |
Design and synthesis of novel tacrine-dipicolylamine dimers that are multiple-target-directed ligands with potential to treat Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amines; Amyloid beta-Peptides; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Drug Design; Humans; Ligands; Molecular Structure; Neuroprotective Agents; Peptide Fragments; Picolinic Acids; Protein Aggregates; Structure-Activity Relationship; Tacrine | 2021 |